HR 6423

0likes☆Favorite🔕SubscribeShare

Introduced ↻ Update bill dataRe-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click. Contact your reps Urge the sponsor

IN THE HOUSE OF REPRESENTATIVES

December 4, 2025

Mr. Kean (for himself, Ms. Barragan, Mrs. Miller-Meeks, Mr. Auchincloss, Mr. Fitzpatrick, and Mrs. Watson Coleman) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Help Ensure Lower Patient Copays Act” or the “HELP Copays Act”.

SEC. 2. APPLICATION OF FINANCIAL ASSISTANCE TOWARD COST-SHARING REQUIREMENTS.

(a) Application Toward Cost-Sharing Requirements.—Section 2715(g)(1) of the Public Health Service Act (42 U.S.C. 300gg-15(g)(1)) is amended by adding at the end the following: “In developing the standards for defining the terms ‘deductible’, ‘coinsurance’, ‘copayment’, and ‘out-of-pocket limit’ (as described in paragraph (2)), such standards shall provide that such terms include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and that such amounts shall be counted toward such deductible, coinsurance, copayment, or limit, respectively.”.

(b) Conforming Amendments.—

(1) PPACA.—Section 1302(c)(3) of the Patient Protection and Affordable Care Act (42 U.S.C. 18022(c)(3)) is amended by adding at the end the following new subparagraph:

“(C) Application of terms.—For purposes of subparagraph (A), the terms ‘deductible’, ‘coinsurance’, ‘copayment’, or ‘similar charge’ and any other expenditure described in clause (ii) of such subparagraph shall include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and such amounts shall be counted toward such deductible, co-insurance, co-payment, charge, or other expenditure, respectively.”.

(2) PHSA.—Section 2707(b) of the Public Health Service Act (42 U.S.C. 300gg-6(b)) is amended by adding at the end the following new sentence: “For purposes of the previous sentence, such limitation shall be applied to prescription drugs as if the reference to ‘essential health benefits’ in section 1302(c)(3) of the Patient Protection and Affordable Care Act were a reference to ‘any item or service covered under the plan included within the prescription drug category of essential health benefits as described in (b)(1)(F) of such section’.”.

(3) Internal revenue code of 1986 safe harbor for certain amounts applied to deductibles.—Section 223(c)(2) of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:

“(H) Safe harbor for certain amounts applied to deductibles.—In the case of plan years beginning after December 31, 2025, a plan shall not fail to be treated as a high deductible health plan by reason of counting amounts paid by, or on behalf of, an individual, including financial assistance offered by non-profit organizations and prescription drug manufacturers for outpatient prescription drugs, when determining whether the minimum deductible under subparagraph (A) has been satisfied.”.

(c) Rule of Construction.—The amendments made by this section shall—

(1) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to prescription drugs that are specialty drugs;

(2) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to drugs that are subject to utilization management; and

(3) not impact the use of utilization management tools, including prior authorization and step therapy.

(d) Effective Date.—This section, and the amendments made by this section, shall apply to group health plans and health insurance issuers for plan years beginning on or after January 1, 2026. <all>